124 related articles for article (PubMed ID: 32027127)
1. Design, Synthesis, and Molecular Modeling Studies of Novel Coumarin Carboxamide Derivatives as eEF-2K Inhibitors.
Comert Onder F; Durdagi S; Sahin K; Ozpolat B; Ay M
J Chem Inf Model; 2020 Mar; 60(3):1766-1778. PubMed ID: 32027127
[TBL] [Abstract][Full Text] [Related]
2. Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth
Comert Onder F; Kahraman N; Bellur Atici E; Cagir A; Kandemir H; Tatar G; Taskin Tok T; Kara G; Karliga B; Durdagi S; Ay M; Ozpolat B
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):926-940. PubMed ID: 33860211
[TBL] [Abstract][Full Text] [Related]
3. Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.
Bircan HA; Gurbuz N; Pataer A; Caner A; Kahraman N; Bayraktar E; Bayraktar R; Erdogan MA; Kabil N; Ozpolat B
Lung Cancer; 2018 Oct; 124():31-39. PubMed ID: 30268477
[TBL] [Abstract][Full Text] [Related]
4. Structure prediction of eukaryotic elongation factor-2 kinase and identification of the binding mechanisms of its inhibitors: homology modeling, molecular docking, and molecular dynamics simulation.
Tatar G; Taskin Tok T; Ozpolat B; Ay M
J Biomol Struct Dyn; 2022; 40(24):13355-13365. PubMed ID: 30880628
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors.
Edupuganti R; Wang Q; Tavares CD; Chitjian CA; Bachman JL; Ren P; Anslyn EV; Dalby KN
Bioorg Med Chem; 2014 Sep; 22(17):4910-6. PubMed ID: 25047940
[TBL] [Abstract][Full Text] [Related]
7. What is the impact of eukaryotic elongation factor 2 kinase on cancer: A systematic review.
Li S; Li Y; Bai Y
Eur J Pharmacol; 2019 Aug; 857():172470. PubMed ID: 31226250
[TBL] [Abstract][Full Text] [Related]
8. Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase.
Cho SI; Koketsu M; Ishihara H; Matsushita M; Nairn AC; Fukazawa H; Uehara Y
Biochim Biophys Acta; 2000 Jul; 1475(3):207-15. PubMed ID: 10913818
[TBL] [Abstract][Full Text] [Related]
9. Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
Tekedereli I; Alpay SN; Tavares CD; Cobanoglu ZE; Kaoud TS; Sahin I; Sood AK; Lopez-Berestein G; Dalby KN; Ozpolat B
PLoS One; 2012; 7(7):e41171. PubMed ID: 22911754
[TBL] [Abstract][Full Text] [Related]
10. Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.
Ashour AA; Abdel-Aziz AA; Mansour AM; Alpay SN; Huo L; Ozpolat B
Apoptosis; 2014 Jan; 19(1):241-58. PubMed ID: 24193916
[TBL] [Abstract][Full Text] [Related]
11. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact.
Devkota AK; Tavares CD; Warthaka M; Abramczyk O; Marshall KD; Kaoud TS; Gorgulu K; Ozpolat B; Dalby KN
Biochemistry; 2012 Mar; 51(10):2100-12. PubMed ID: 22352903
[TBL] [Abstract][Full Text] [Related]
12. Novel inhibitors of eukaryotic elongation factor 2 kinase: In silico, synthesis and in vitro studies.
Onder FC; Durdagi S; Kahraman N; Uslu TN; Kandemir H; Atici EB; Ozpolat B; Ay M
Bioorg Chem; 2021 Nov; 116():105296. PubMed ID: 34488125
[TBL] [Abstract][Full Text] [Related]
13. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor.
Piserchio A; Isiorho EA; Dalby KN; Ghose R
J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli.
Abramczyk O; Tavares CD; Devkota AK; Ryazanov AG; Turk BE; Riggs AF; Ozpolat B; Dalby KN
Protein Expr Purif; 2011 Oct; 79(2):237-44. PubMed ID: 21605678
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanism of eukaryotic elongation factor 2 kinase activation.
Tavares CD; Ferguson SB; Giles DH; Wang Q; Wellmann RM; O'Brien JP; Warthaka M; Brodbelt JS; Ren P; Dalby KN
J Biol Chem; 2014 Aug; 289(34):23901-16. PubMed ID: 25012662
[TBL] [Abstract][Full Text] [Related]
16. ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin.
Piserchio A; Long KJ; Browning LS; Bohanon AL; Isiorho EA; Dalby KN; Ghose R
Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2300902120. PubMed ID: 37068230
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-elongation factor 2 kinase (calmodulin-dependent protein kinase III) antibodies in patients with systemic lupus erythematosus.
Arora S; Yang JM; Craft J; Hait W
Biochem Biophys Res Commun; 2002 May; 293(3):1073-6. PubMed ID: 12051769
[TBL] [Abstract][Full Text] [Related]
18. Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION.
Tavares CDJ; Giles DH; Stancu G; Chitjian CA; Ferguson SB; Wellmann RM; Kaoud TS; Ghose R; Dalby KN
J Biol Chem; 2017 Feb; 292(5):2032-2045. PubMed ID: 27956550
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic elongation factor-2 kinase regulates the cross-talk between autophagy and pyroptosis in doxorubicin-treated human melanoma cells in vitro.
Yu P; Wang HY; Tian M; Li AX; Chen XS; Wang XL; Zhang Y; Cheng Y
Acta Pharmacol Sin; 2019 Sep; 40(9):1237-1244. PubMed ID: 30914761
[TBL] [Abstract][Full Text] [Related]
20. Reversible covalent inhibition of eEF-2K by carbonitriles.
Devkota AK; Edupuganti R; Yan C; Shi Y; Jose J; Wang Q; Kaoud TS; Cho EJ; Ren P; Dalby KN
Chembiochem; 2014 Nov; 15(16):2435-42. PubMed ID: 25224652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
